Receivers have detailed plans to secure the future of the hospital operator Healthscope’s receivers say they’ve come up with a plan that will give “stability to Australia’s hospital system”, which …

Action has been launched in the NSW Supreme Court after the takeover agreement was pulled Mayne Pharma is suing its US ex-suitor Cosette and its private equity backer Avista Healthcare …

In the wake of their merger pay day, the three founders’ net worth has been revealed by Forbes magazine, with another pharmacy name joining the top 25 wealthiest Australians Chemist …

The global biotech dropped its CEO and saw its share price plummet after flagging a fall in profit, competition in iron generics and the impact of US vaccine policy Melbourne-based …

A national chain has detailed its strategy to grow its footprint and put pharmacists centre stage, as it revamps its network of 46 stores The new leader of South Australia-helmed …

Reports of GLP-1s being prescribed to vulnerable Australians have alarmed eating disorder support organisations, but regulators say there is no rise in associated cases The national medicines regulator says it …

An ASX-listed pharmacy engagement company will shift focus amid changes to vaccine uptake in the US Pharmacy management platform Adheris Health – formerly MedAdvisor – plans to reduce its reliance …

The collapsed pharmacy group’s receivers are targeting a bulk sale, with a source revealing how many potential suitors have lined up – and others sharing concerns about competition A campaign …

Sunscreen is a staple for pharmacies and their customers, however, recent investigations by Choice and the TGA have cast doubt over makers’ SPF claims In pharmacies across Australia, top-selling sunscreens …

The medicines regulator has issued a warning about fake melatonin products, with tests showing they vary wildly in their make-up The Therapeutic Goods Administration (TGA) has raised the alarm about …

Pharmacy-driven platform Adheris Health, formerly known as MedAdvisor Solutions, says it received a final deferred sum for the sale of its Australian and New Zealand arm The e-health company says …

Pharmacists have been given the OK to substitute the 200mg dosage of the high blood pressure medication  A manufacturing shortage has prompted a new Serious Scarcity Substitution Instrument (SSSI) for …